Hisamitsu Pharmaceutical Co Stock Book Value Per Share
| HTSUF Stock | USD 25.22 0.00 0.00% |
Hisamitsu Pharmaceutical Co fundamentals help investors to digest information that contributes to Hisamitsu Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Hisamitsu Pink Sheet. The fundamental analysis module provides a way to measure Hisamitsu Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hisamitsu Pharmaceutical pink sheet.
Hisamitsu |
Hisamitsu Pharmaceutical Co Company Book Value Per Share Analysis
Hisamitsu Pharmaceutical's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current Hisamitsu Pharmaceutical Book Value Per Share | 3,393 X |
Most of Hisamitsu Pharmaceutical's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hisamitsu Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
CompetitionIn accordance with the recently published financial statements, the book value per share of Hisamitsu Pharmaceutical Co is about 3.39 K times. This is 199696.88% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The book value per share for all United States stocks is 75.67% lower than that of the firm.
Hisamitsu Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hisamitsu Pharmaceutical's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Hisamitsu Pharmaceutical could also be used in its relative valuation, which is a method of valuing Hisamitsu Pharmaceutical by comparing valuation metrics of similar companies.Hisamitsu Pharmaceutical is currently under evaluation in book value per share category among related companies.
Hisamitsu Fundamentals
| Return On Equity | 0.0504 | |||
| Return On Asset | 0.0212 | |||
| Profit Margin | 0.10 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 1.15 B | |||
| Shares Outstanding | 79.53 M | |||
| Shares Owned By Insiders | 26.45 % | |||
| Shares Owned By Institutions | 35.26 % | |||
| Price To Earning | 22.53 X | |||
| Price To Book | 0.97 X | |||
| Price To Sales | 0.02 X | |||
| Revenue | 120.19 B | |||
| Gross Profit | 70.07 B | |||
| EBITDA | 17.3 B | |||
| Net Income | 9.66 B | |||
| Cash And Equivalents | 151.32 B | |||
| Total Debt | 219 M | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 4.46 X | |||
| Book Value Per Share | 3,393 X | |||
| Cash Flow From Operations | 19.2 B | |||
| Earnings Per Share | 1.06 X | |||
| Number Of Employees | 2.78 K | |||
| Beta | 0.51 | |||
| Market Capitalization | 2.45 B | |||
| Total Asset | 302.86 B | |||
| Retained Earnings | 216.56 B | |||
| Working Capital | 133.88 B | |||
| Current Asset | 171.81 B | |||
| Current Liabilities | 37.93 B | |||
| Z Score | 6.6 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 302.86 B | |||
| Last Dividend Paid | 42.0 |
About Hisamitsu Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hisamitsu Pharmaceutical Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hisamitsu Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hisamitsu Pharmaceutical Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for Hisamitsu Pink Sheet analysis
When running Hisamitsu Pharmaceutical's price analysis, check to measure Hisamitsu Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hisamitsu Pharmaceutical is operating at the current time. Most of Hisamitsu Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Hisamitsu Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hisamitsu Pharmaceutical's price. Additionally, you may evaluate how the addition of Hisamitsu Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |